Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1963;27:5-11

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LINENTHAL, A. J.
Right arrow Articles by ZOLL, P. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LINENTHAL, A. J.
Right arrow Articles by ZOLL, P. M.

(Circulation. 1963;27:5.)
© 1963 American Heart Association, Inc.


Prevention of Ventricular Tachycardia and Fibrillation by Intravenous Isoproterenol and Epinephrine

ARTHUR J. LINENTHAL M.D.1 PAUL M. ZOLL M.D.1

1 From the Medical Research Department, Beth Israel Hospital, and the Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Isoproterenol and epinephrine were given intravenously in dilute solutions to nine patients with Stokes-Adams attacks due to ventricular tachycardia and fibrillation. The drugs produced ventricular acceleration and thereby controlled the attacks. This technic proved useful for prompt, short-term prevention of seizures; for the long term, direct electric stimulation with internal pacemakers was required.